Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for idiopathic intracranial hypertension
ACTRN12625000401459Phase 2Recruiting
- Sponsor
- The Alfred Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic intracranial hypertension (IIH) comparing Empagliflozin with Placebo (2 arms). Primary endpoint: Intracranial pressure measured by lumbar puncture opening pressure. Started Jul 2025; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on ACTRN12625000401459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000401459.